CoChat

Amyloid, tau and metabolic PET correlates of cognition in early and late-onset Alzheimer’s disease

Open access
Tanner, Jeremy A, Iaccarino, Leonardo, Edwards, Lauren, Asken, Breton M, Gorno-Tempini, Maria L, Kramer, Joel H, Pham, Julie, Perry, David C, Possin, Katherine, Malpetti, Maura, Mellinger, Taylor, Miller, Bruce L, Miller, Zachary, Mundada, Nidhi S, Rosen, Howard J, Soleimani-Meigooni, David N, Strom, Amelia, La Joie, Renaud, Rabinovici, Gil D · 2022 · Brain
Cited by 91

The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.

Abstract

Early-onset (age < 65) Alzheimer’s disease is associated with greater non-amnestic cognitive symptoms and neuropathological burden than late-onset disease. It is not fully understood whether these groups also differ in the associations between molecular pathology, neurodegeneration and cognitive performance. We studied amyloid-positive patients with early-onset (n = 60, mean age 58 ± 4, MMSE 21 ± 6, 58% female) and late-onset (n = 53, mean age 74 ± 6, MMSE 23 ± 5, 45% female) Alzheimer’s disease who underwent neurological evaluation, neuropsychological testing, 11C-Pittsburgh compound B PET (amyloid-PET) and 18F-flortaucipir PET (tau-PET). 18F-fluorodeoxyglucose PET (brain glucose metabolism PET) was also available in 74% (n = 84) of participants. Composite scores for episodic memory, semantic memory, language, executive function and visuospatial domains were calculated based on cognitively unimpaired controls. Voxel-wise regressions evaluated correlations between PET biomarkers and cognitive scores and early-onset versus late-onset differences were tested with a PET × Age group interaction. Mediation analyses estimated direct and indirect (18F-fluorodeoxyglucose mediated) local associations between 18F-flortaucipir binding and cognitive scores in domain-specific regions of interest. We found that early-onset patients had higher 18F-flortaucipir binding in parietal, lateral temporal and lateral frontal cortex; more severe 18F-fluorodeoxyglucose hypometabolism in the precuneus and angular gyrus; and greater 11C-Pittsburgh compound B binding in occipital regions compared to late-onset patients. In our primary analyses, PET–cognition correlations did not meaningfully differ between age groups.18F-flortaucipir and 18F-fluorodeoxyglucose, but not 11C-Pittsburgh compound B, were significantly associated with cognition in expected domain-specific patterns in both age groups (e.g. left perisylvian/language, frontal/executive, occipital/visuospatial). 18F-fluorodeoxyglucose mediated the relationship between 18F-flortaucipir and cognition in both age groups across all domains except episodic memory in late-onset patients. Additional direct effects of 18F-flortaucipir were observed for executive function in all age groups, language in early-onset Alzheimer’s disease and in the total sample and visuospatial function in the total sample. In conclusion, tau and neurodegeneration, but not amyloid, were similarly associated with cognition in both early and late-onset Alzheimer’s disease. Tau had an association with cognition independent of neurodegeneration in language, executive and visuospatial functions in the total sample. Our findings support tau PET as a biomarker that captures both the clinical severity and molecular pathology specific to Alzheimer’s disease across the broad spectrum of ages and clinical phenotypes in Alzheimer’s disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/brain/awac229

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 48 references

Research works printed but not linked: 63

  1. Lambert, 2014, Estimating the burden of early onset dementia; Systematic review of disease prevalence, Eur J Neurol, 21, 563, 10.1111/ene.12325 · DOI · Paper page
  2. Zhu, 2015, Rate of early onset Alzheimer’s disease: A systematic review and meta-analysis, Ann Transl Med, 3, 38
  3. Jarmolowicz, 2015, The patterns of inheritance in early-onset dementia: Alzheimer’s disease and frontotemporal dementia, Am J Alzheimers Dis Other Demen, 30, 299, 10.1177/1533317514545825 · DOI · Paper page
  4. Ho, 2002, Age at onset is associated with disease severity in Lewy body variant and Alzheimer’s disease, Neuroreport, 13, 1825, 10.1097/00001756-200210070-00028 · DOI · Paper page
  5. Davidson, 2011, TDP-43 pathological changes in early onset familial and sporadic Alzheimer’s disease, late onset Alzheimer’s disease and Down’s syndrome: Association with age, hippocampal sclerosis and clinical phenotype, Acta Neuropathol, 122, 703, 10.1007/s00401-011-0879-y · DOI
  6. Lawlor, 1994, Clinical symptoms associated with age at onset in Alzheimer’s disease, The American Journal of Psychiatry, 151, 1646, 10.1176/ajp.151.11.1646 · DOI · Paper page
  7. Palasí, 2015, Differentiated clinical presentation of early and late-onset Alzheimer’s disease: Is 65 years of age providing a reliable threshold?, J Neurol, 262, 1238, 10.1007/s00415-015-7698-3 · DOI
  8. Joubert, 2016, Early-onset and late-onset Alzheimer’s disease are associated with distinct patterns of memory impairment, Cortex, 74, 217, 10.1016/j.cortex.2015.10.014 · DOI
  9. Mendez, 2017, Neurol Clin, 35, 263, 10.1016/j.ncl.2017.01.005 · DOI · Paper page
  10. Bentham, 2005, Services for younger people with dementia, Psychiatry, 4, 100, 10.1383/psyt.4.2.100.59105 · DOI
  11. Wattmo, 2017, Early- versus late-onset Alzheimer’s disease in clinical practice: Cognitive and global outcomes over 3 years, Alzheimers Res Ther, 9, 70, 10.1186/s13195-017-0294-2 · DOI · Paper page
  12. Chang, 2017, Mortality risk after diagnosis of early-onset Alzheimer’s disease versus late-onset Alzheimer’s disease: A propensity score matching analysis, J Alzheimers Dis, 56, 1341, 10.3233/JAD-161181 · DOI
  13. Klunk, 2004, Imaging brain amyloid in Alzheimer’s disease with Pittsburgh compound-B, Ann Neurol, 55, 306, 10.1002/ana.20009 · DOI · Paper page
  14. Cho, 2013, Amyloid deposition in early onset versus late onset Alzheimer’s disease, J Alzheimers Dis, 35, 813, 10.3233/JAD-121927 · DOI · Paper page
  15. Rabinovici, 2010, Increased metabolic vulnerability in early-onset Alzheimer’s disease is not related to amyloid burden, Brain, 133, 512, 10.1093/brain/awp326 · DOI · Paper page
  16. La Joie, 2021, Association of APOE4 and clinical variability in Alzheimer disease with the pattern of tau- and amyloid-PET, Neurology, 96, e650, 10.1212/WNL.0000000000011270 · DOI · Paper page
  17. Marquié, 2015, Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue, Ann Neurol, 78, 787, 10.1002/ana.24517 · DOI · Paper page
  18. Whitwell, 2018, Imaging correlations of tau, amyloid, metabolism, and atrophy in typical and atypical Alzheimer’s disease, Alzheimers Dement, 14, 1005, 10.1016/j.jalz.2018.02.020 · DOI · Paper page
  19. Iaccarino, 2021, Spatial relationships between molecular pathology and neurodegeneration in the Alzheimer’s disease continuum, Cereb Cortex, 31, 1, 10.1093/cercor/bhaa184 · DOI · Paper page
  20. Josephs, 2020, MRI And flortaucipir relationships in Alzheimer’s phenotypes are heterogeneous, Ann Clin Transl Neurol, 7, 707, 10.1002/acn3.51038 · DOI
  21. Visser, 2020, Tau pathology and relative cerebral blood flow are independently associated with cognition in Alzheimer’s disease, Eur J Nucl Med Mol Imaging, 47, 3165, 10.1007/s00259-020-04831-w · DOI
  22. Kim, 2005, Glucose metabolism in early onset versus late onset Alzheimer’s disease: An SPM analysis of 120 patients, Brain, 128, 1790, 10.1093/brain/awh539 · DOI · Paper page
  23. Aziz, 2017, Difference in imaging biomarkers of neurodegeneration between early and late-onset amnestic Alzheimer’s disease, Neurobiol Aging, 54, 22, 10.1016/j.neurobiolaging.2017.02.010 · DOI
  24. Lehmann, 2013, Diverging patterns of amyloid deposition and hypometabolism in clinical variants of probable Alzheimer’s disease, Brain, 136, 844, 10.1093/brain/aws327 · DOI · Paper page
  25. Koychev, 2017, PET Tau and amyloid-β burden in mild Alzheimer’s disease: Divergent relationship with age, cognition, and cerebrospinal fluid biomarkers, J Alzheimers Dis, 60, 283, 10.3233/JAD-170129 · DOI · Paper page
  26. Bejanin, 2017, Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer’s disease, Brain, 140, 3286, 10.1093/brain/awx243 · DOI · Paper page
  27. Digma, 2019, Tau and atrophy: Domain-specific relationships with cognition, Alzheimers Res Ther, 11, 65, 10.1186/s13195-019-0518-8 · DOI
  28. Sintini, 2019, Regional multimodal relationships between tau, hypometabolism, atrophy, and fractional anisotropy in atypical Alzheimer’s disease, Hum Brain Mapp, 40, 1618, 10.1002/hbm.24473 · DOI · Paper page
  29. Boon, 2020, The coarse-grained plaque: a divergent aβ plaque-type in early-onset Alzheimer’s disease, Acta Neuropathol, 140, 811, 10.1007/s00401-020-02198-8 · DOI · Paper page
  30. McKhann, 2011, The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging–Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease, Alzheimers Dement, 7, 263, 10.1016/j.jalz.2011.03.005 · DOI · Paper page
  31. Albert, 2011, The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging–Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease, Alzheimers Dement, 7, 270, 10.1016/j.jalz.2011.03.008 · DOI · Paper page
  32. Gorno-Tempini, 2011, Classification of primary progressive aphasia and its variants, Neurology, 76, 1006, 10.1212/WNL.0b013e31821103e6 · DOI · Paper page
  33. Kramer, 2003, Distinctive neuropsychological patterns in frontotemporal dementia, semantic dementia, and Alzheimer disease, Cogn Behav Neurol, 16, 211, 10.1097/00146965-200312000-00002 · DOI · Paper page
  34. Nys, 2005, Restrictions of the Mini-Mental State Examination in acute stroke, Arch Clin Neuropsychol, 20, 623, 10.1016/j.acn.2005.04.001 · DOI · Paper page
  35. Lesman-Segev, 2019, Tau PET and multimodal brain imaging in patients at risk for chronic traumatic encephalopathy, Neuroimage Clin, 24, 102025, 10.1016/j.nicl.2019.102025 · DOI
  36. Baker, 2017, Considerations and code for partial volume correcting [18F]-AV-1451 tau PET data, Data Brief, 15, 648, 10.1016/j.dib.2017.10.024 · DOI · Paper page
  37. Müller-Gärtner, 1992, Measurement of radiotracer concentration in brain gray matter using positron emission tomography: MRI-based correction for partial volume effects, J Cereb Blood Flow Metab, 12, 571, 10.1038/jcbfm.1992.81 · DOI · Paper page
  38. MATLAB, 2015, Version 8.5.0.197613(R2015a)
  39. Wickham, 2009, Ggplot2: Elegant graphics for data analysis, 10.1007/978-0-387-98141-3 · DOI · Paper page
  40. Tingley, 2014, Mediation: R package for causal mediation analysis, J Stat Softw, 59, 1, 10.18637/jss.v059.i05 · DOI · Paper page
  41. Petersen, 2019, Alzheimer’s disease clinical variants show distinct regional patterns of neurofibrillary tangle accumulation, Acta Neuropathol, 138, 597, 10.1007/s00401-019-02036-6 · DOI · Paper page
  42. Furst, 2012, Cognition, glucose metabolism and amyloid burden in Alzheimer’s disease, Neurobiol Aging, 33, 215, 10.1016/j.neurobiolaging.2010.03.011 · DOI · Paper page
  43. Ossenkoppele, 2019, Associations between tau, aβ, and cortical thickness with cognition in Alzheimer disease, Neurology, 92, e601, 10.1212/WNL.0000000000006875 · DOI · Paper page
  44. Villemagne, 2013, Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer’s disease: A prospective cohort study, Lancet Neurol, 12, 357, 10.1016/S1474-4422(13)70044-9 · DOI · Paper page
  45. Santos, 2012, Amyloid-β oligomers in cerebrospinal fluid are associated with cognitive decline in patients with Alzheimer’s disease, J Alzheimers Dis, 29, 171, 10.3233/JAD-2012-111361 · DOI · Paper page
  46. Meng, 2019, Association between increased levels of amyloid-β oligomers in plasma and episodic memory loss in Alzheimer’s disease, Alzheimers Res Ther, 11, 89, 10.1186/s13195-019-0535-7 · DOI
  47. Posner, 1988, Localization of cognitive operations in the human brain, Science, 240, 1627, 10.1126/science.3289116 · DOI · Paper page
  48. Chertkow, 2008, Cognitive neuroscience studies of semantic memory in Alzheimer’s disease, Prog Brain Res, 169, 393, 10.1016/S0079-6123(07)00025-8 · DOI
  49. Peelle, 2014, Frontotemporal neural systems supporting semantic processing in Alzheimer’s disease, Cogn Affect Behav Neurosci, 14, 37, 10.3758/s13415-013-0239-6 · DOI
  50. Yeo, 2011, The organization of the human cerebral cortex estimated by intrinsic functional connectivity, J Neurophysiol, 106, 1125, 10.1152/jn.00338.2011 · DOI · Paper page
  51. Hansson, 2017, Tau pathology distribution in Alzheimer’s disease corresponds differentially to cognition-relevant functional brain networks, Front Neurosci, 11, 167, 10.3389/fnins.2017.00167 · DOI · Paper page
  52. Jones, 2016, Cascading network failure across the Alzheimer’s disease spectrum, Brain, 139, 547, 10.1093/brain/awv338 · DOI · Paper page
  53. Xia, 2017, Association of in vivo [18F]AV-1451 tau PET imaging results with cortical atrophy and symptoms in typical and atypical Alzheimer disease, JAMA Neurol, 74, 427, 10.1001/jamaneurol.2016.5755 · DOI · Paper page
  54. Maass, 2018, Entorhinal tau pathology, episodic memory decline, and neurodegeneration in aging, J Neurosci, 38, 530, 10.1523/JNEUROSCI.2028-17.2017 · DOI · Paper page
  55. Hanseeuw, 2019, Association of amyloid and tau with cognition in preclinical Alzheimer disease, JAMA Neurol, 76, 915, 10.1001/jamaneurol.2019.1424 · DOI · Paper page
  56. Miller, 2013, Handedness and language learning disability differentially distribute in progressive aphasia variants, Brain, 136, 3461, 10.1093/brain/awt242 · DOI · Paper page
  57. Miller, 2018, Prevalence of mathematical and visuospatial learning disabilities in patients with posterior cortical atrophy, JAMA Neurol, 75, 728, 10.1001/jamaneurol.2018.0395 · DOI · Paper page
  58. Franzmeier, 2020, Patient-centered connectivity-based prediction of tau pathology spread in Alzheimer’s disease, Sci Adv, 6, eabd1327, 10.1126/sciadv.abd1327 · DOI · Paper page
  59. Vogel, 2020, Spread of pathological tau proteins through communicating neurons in human Alzheimer’s disease, Nat Commun, 11, 2612, 10.1038/s41467-020-15701-2 · DOI · Paper page
  60. Mattsson, 2019, Predicting diagnosis and cognition with 18F-AV-1451 tau PET and structural MRI in Alzheimer’s disease, Alzheimers Dement, 15, 570, 10.1016/j.jalz.2018.12.001 · DOI · Paper page
  61. Park, 2020, Tau induces PSD95–neuronal NOS uncoupling and neurovascular dysfunction independent of neurodegeneration, Nat Neurosci, 23, 1079, 10.1038/s41593-020-0686-7 · DOI · Paper page
  62. Albrecht, 2020, Associations between vascular function and tau PET are associated with global cognition and amyloid, J Neurosci, 40, 8573, 10.1523/JNEUROSCI.1230-20.2020 · DOI
  63. Jones, 2017, Tau, amyloid, and cascading network failure across the Alzheimer’s disease spectrum, Cortex, 97, 143, 10.1016/j.cortex.2017.09.018 · DOI · Paper page

Cited by

See all 91

Metadata

Authors
Tanner, J. A., Iaccarino, L., Edwards, L., Asken, B. M., Gorno-Tempini, M. L., Kramer, J. H., Pham, J., Perry, D. C., Possin, K., Malpetti, M., Mellinger, T., Miller, B. L., Miller, Z., Mundada, N. S., Rosen, H. J., Soleimani-Meigooni, D. N., Strom, A., La Joie, R., & Rabinovici, G. D.
Venue
Brain
Published
2022-06-28
Volume
145
Issue
12
Pages
4489-4505
ISSN
  • 0006-8950 (ISSN-L)
  • 1460-2156
OpenAlex
W4283687741
Cited by
91
References
48
FWCI
10.33
Type
journal article
Language
en
Open access
bronze
Funders
  • National Institute on Aging (P30-AG062422)
  • Alzheimer’s Disease Research Center (P01-AG019724, R35-AG072362, K99 AG065501, R01 AG045611)
  • Alzheimer’s Association (AACSF-19-617663)
  • Rainwater Charitable Foundation
  • Race Against Dementia Alzheimer’s Research UK (ARUK-RADF2021A-010)
  • Cambridge University Centre for Parkinson-Plus (RG95450)
  • National Institute for Health Research Cambridge Biomedical Research Centre (BRC-1215-20014)
  • Department of Health and Social Care
  • NIH

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Amyloid, tau and metabolic PET correlates of cognition in early and late-onset Alzheimer’s disease. https://app.cochat.ai/papers/10.1093/brain/awac229
The paper
Tanner, J. A., Iaccarino, L., Edwards, L., Asken, B. M., Gorno-Tempini, M. L., Kramer, J. H., Pham, J., Perry, D. C., Possin, K., Malpetti, M., Mellinger, T., Miller, B. L., Miller, Z., Mundada, N. S., Rosen, H. J., Soleimani-Meigooni, D. N., Strom, A., La Joie, R., & Rabinovici, G. D. (2022). Amyloid, tau and metabolic PET correlates of cognition in early and late-onset Alzheimer’s disease. Brain. https://doi.org/10.1093/brain/awac229

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.